Floatz logo

dnp007

Liver Transplant; Complications

Seoul National University HospitalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Liver Transplant; Complications cohort.

Asset / SponsorPhaseRating
TACROLIMUS
The Second Hospital of Tangshan
Phase 4BBB
Giapreza
University of California, San Francisco
Phase 4BBB
Equine Atg
University Hospital, Toulouse
Phase 4BB
Everolimus
Novartis Pharmaceuticals
Phase 3BB
Semaglutide
University Health Network, Toronto
Phase 4BB

View all 35 →

Same molecule, other indications

dnp007 is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
CC
Indicative ·
43 / 100
View asset →
transplant rejectionDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →